About CMME
Overview
CMME (Company registration in Hong Kong, founded 10 July 2020) presents itself as a derivatives trading entity. Its official domain, 58swiss.shop, is an unusual e-commerce-style address, which raises questions about its operational transparency. The broker is regulated in Hong Kong by the Securities and Futures Commission (SFC) under a Derivatives Trading License (AGN), though the current status of that licence is not publicly confirmed. Independent user reviews are absent, and limited publicly available information makes it difficult to assess the full scope of its services.
Given the guarded risk score of 47/100 assigned by FXCanary, traders should approach CMME with caution. The lack of a conventional broker website or clearly stated trading platforms, instruments, and account types means that potential clients must rely on direct inquiries for basic details. This broker may be best suited for experienced, regionally restricted traders who can verify its licensing status independently.
Regulation & Licensing
CMME's sole regulatory filing is with the Hong Kong Securities and Futures Commission (SFC) for a Derivatives Trading License (licence code AGN). The SFC is a respected financial regulator, but the status of this licence (e.g., active, suspended, or cancelled) is not recorded in our data. Traders should verify the licence directly via the SFC's public register before committing funds.
The absence of any other regulatory oversight, especially from top-tier jurisdictions, adds to the risk profile. While Hong Kong regulation is generally robust, the unclear status and the broker's obscure web presence diminish confidence. We recommend proceeding only with verifiable licensing and thorough due diligence.
Risk Assessment
FXCanary’s Scam Risk Score of 47/100 places CMME in the “Guarded” zone, indicating elevated concerns. The low web confidence (no matching web results) amplifies these concerns, as the broker lacks a transparent online footprint. Key risk factors include: an unconventional domain name, absence of independent client reviews, and incomplete regulatory status.
Potential warning signs are the mismatch between a Hong Kong-regulated derivatives firm and a .shop domain, which is atypical for financial services. The founding date (July 2020) makes it relatively new, yet it has not cultivated a public presence. Until more information emerges, this broker carries inherent risks that may outweigh benefits for most retail traders.
Target Audience
Based on available information, CMME likely targets professional or institutional clients within Hong Kong or Asia-Pacific who have direct access to SFC-regulated entities. The absence of marketing toward retail traders suggests a focused, perhaps invite-only clientele. However, the lack of a clear public offering implies that only sophisticated investors with specific needs (e.g., custom derivatives) would find this broker relevant.
For the average retail forex trader, CMME appears unsuitable due to transparency deficits. Beginners should avoid this broker until it establishes a credible, user-friendly presence and resolves regulatory ambiguities.
Conclusion
CMME remains an obscure entity with limited independent verification. Its Hong Kong SFC derivatives licence is a positive sign, but the questionable domain and unclear operational status temper that assurance. The guarded risk score reflects a balanced view: not overtly fraudulent but lacking the hallmarks of a trustworthy broker.
Traders considering CMME must take proactive steps: verify the SFC licence status, request detailed information about instruments, platforms, and account terms, and insist on a clear withdrawal process. Until substantial public information emerges, the broker occupies a grey area that prudent traders will avoid.
Overview compiled by FXCanary from regulatory records and public data. full CMME review